Inspire Medical Systems Files 8-K

Ticker: INSP · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1609550

Inspire Medical Systems, INC. 8-K Filing Summary
FieldDetail
CompanyInspire Medical Systems, INC. (INSP)
Form Type8-K
Filed DateJan 13, 2025
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, operations, disclosure

TL;DR

Inspire Medical Systems dropped an 8-K on Jan 13th covering financials and operations.

AI Summary

Inspire Medical Systems, Inc. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Golden Valley, Minnesota.

Why It Matters

This 8-K filing provides crucial updates on Inspire Medical Systems' financial performance and operational status, which can influence investor decisions.

Risk Assessment

Risk Level: low — This filing is a standard 8-K reporting routine financial and operational information, not indicating any immediate or unusual risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Inspire Medical Systems, Inc.?

The primary purpose is to report on the company's Results of Operations and Financial Condition, along with Regulation FD Disclosures and Financial Statements and Exhibits.

On what date was the earliest event reported in this filing?

The earliest event reported in this filing was on January 13, 2025.

In which state is Inspire Medical Systems, Inc. incorporated?

Inspire Medical Systems, Inc. is incorporated in Delaware.

What is the address of Inspire Medical Systems, Inc.'s principal executive offices?

The address of the principal executive offices is 5500 Wayzata Blvd., Suite 1600, Golden Valley, Minnesota 55416.

What is the company's telephone number, including area code?

The company's telephone number is (844) 672-4357.

Filing Stats: 636 words · 3 min read · ~2 pages · Grade level 9.3 · Accepted 2025-01-13 06:48:21

Key Financial Figures

Filing Documents

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On January 13, 2025, Inspire Medical Systems, Inc. (the "Company") issued a press release announcing certain preliminary and unaudited results for the quarter and full year ended December 31, 2024. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. In January of 2025, the Company will be participating in various meetings with investors and analysts, and a copy of the Company's presentation materials being used at these meetings is furnished as Exhibit 99.2 hereto and is incorporated herein by reference. These presentation materials are also available on the Investor Relations page of the Company's website at https://investors.inspiresleep.com. The information in each of Item 2.02 and Item 7.01 of this Current Report on Form 8-K and in the press release attached as Exhibit 99.1 and the presentation attached as Exhibit 99.2 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release of Inspire Medical Systems, Inc., dated January 13, 2025. 99.2 Inspire Medical Systems, Inc. Presentation, January 2025 . 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIRE MEDICAL SYSTEMS, INC. Date: January 13, 2025 By: /s/ Richard J. Buchholz Richard J. Buchholz Chief Financial Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing